| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/2006 | EP1358169B1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 01/11/2006 | EP1353660B1 Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 01/11/2006 | EP1341412B1 Indolocarbazole anticancer agents and methods of using them |
| 01/11/2006 | EP1340753B1 Carbamate derivatives, process for producing the same and use thereof |
| 01/11/2006 | EP1320375B1 Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1294402B1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/11/2006 | EP1256342B1 Hypoglycemics comprising organic zinc (ii) complexes |
| 01/11/2006 | EP1240328B1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 01/11/2006 | EP1198225B1 Epothilone compositions |
| 01/11/2006 | EP1161265A4 Method for the identification and removal of nits from hair |
| 01/11/2006 | EP1156830B1 Use of an oil-in-water emulsion for the manufacture of a medicament |
| 01/11/2006 | EP1142573B1 Pharmaceutical compositions comprising faropenem sodium and a diamineacetate compound for improving gastrointestinal absorption |
| 01/11/2006 | EP1133459B1 Sertraline hydrochloride form v |
| 01/11/2006 | EP1133291B1 Cyclic polyamines for treating thrombocytopenia |
| 01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 01/11/2006 | EP1131310B1 Chrystals of 5- 6-(2-fluorobenzyl)oxy-2-naphthyl methyl]-2,4-thiazolidinedione |
| 01/11/2006 | EP1124839B1 Nucleosides with anti-hepatitis b virus activity |
| 01/11/2006 | EP1119630B1 Nucleic acid constructs for genetic immunisation |
| 01/11/2006 | EP1104297B1 Compositions for the treatment of chronic lymphocytic leukemia |
| 01/11/2006 | EP1056732B1 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
| 01/11/2006 | EP1047422B1 Use of histamine for elevating blood histamine levels |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | EP1009768B1 Human persephin |
| 01/11/2006 | EP1001035B1 Novel antibiotics rk-1061 and process for preparing the same |
| 01/11/2006 | EP0989805B1 Nucleic acid sequences for atp-binding cassette transporter |
| 01/11/2006 | EP0954321B1 Synergistic compositions containing gold and a corticosteroid |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | EP0941064B1 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF beta -LACTAM ANTIBIOTICS |
| 01/11/2006 | EP0930883B1 Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain |
| 01/11/2006 | EP0868519B1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 01/11/2006 | EP0859610B1 Ibogamine congeners |
| 01/11/2006 | EP0831912B1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 01/11/2006 | EP0823913B1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 01/11/2006 | EP0822822A4 Controlled release of miotic and mydriatic drugs in the anterior chamber |
| 01/11/2006 | EP0821692B1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720265A Chitosan-containing polysaccharide, method for preparing the same and use thereof |
| 01/11/2006 | CN1720257A Methods of down regulating target gene expression in vivo by introduction of interfering RNA |
| 01/11/2006 | CN1720250A Solid-phase saccharide sensing compounds |
| 01/11/2006 | CN1720248A Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 01/11/2006 | CN1720246A (Purin-6-yl) amino acid and production method thereof |
| 01/11/2006 | CN1720243A Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 01/11/2006 | CN1720242A Synthetic lactone formulations and method of use |
| 01/11/2006 | CN1720240A Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands |
| 01/11/2006 | CN1720239A Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and high pure crystals of zonisamide |
| 01/11/2006 | CN1720237A 3h-quinazolin-4-one derivatives |
| 01/11/2006 | CN1720236A 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
| 01/11/2006 | CN1720235A 1-N-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 01/11/2006 | CN1720232A Tetandrine and tetrandrine compound, synthesis and application |
| 01/11/2006 | CN1720231A Substituted dihydrophenanthridinesulfonamides |
| 01/11/2006 | CN1720227A N-arylsulfonyl-3-aminoalkoxyindoles |
| 01/11/2006 | CN1720226A Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 01/11/2006 | CN1720225A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
| 01/11/2006 | CN1720219A Fused bicyclic or tricyclic amino acids |
| 01/11/2006 | CN1720065A Dispersible pharmaceutical compositions |
| 01/11/2006 | CN1720061A Compounds that bind P2Y2 or P2Y1 receptors |
| 01/11/2006 | CN1720057A Chinese patent medicine for treating baldness and preparing process thereof |
| 01/11/2006 | CN1720054A Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
| 01/11/2006 | CN1720053A Method of reducing toxicity of anticancer agents |
| 01/11/2006 | CN1720052A Treatment of diabetes |
| 01/11/2006 | CN1720051A Fat regulation |
| 01/11/2006 | CN1720050A Improved imaging agents comprising barbituric acid derivatives |
| 01/11/2006 | CN1720049A Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 01/11/2006 | CN1720048A Method and compositions for treating anxiety |
| 01/11/2006 | CN1720047A PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/11/2006 | CN1720046A 5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia |
| 01/11/2006 | CN1720045A Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 01/11/2006 | CN1720044A Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome |
| 01/11/2006 | CN1720043A Non-nucleoside reverse transcriptase inhibitors |
| 01/11/2006 | CN1720042A Combination of an dpp-iv inhibitor and a ppar-alpha compound |
| 01/11/2006 | CN1720041A Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 01/11/2006 | CN1720040A Remedy |
| 01/11/2006 | CN1720039A Use of docosahexanoic acid as active substance for the treatment of lipodystrophy |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720037A Painless injectable compositions containing salt of 2-arylpropionic acids |
| 01/11/2006 | CN1720036A Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 01/11/2006 | CN1720035A Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| 01/11/2006 | CN1720034A Methods of inducing terminal differentiation |
| 01/11/2006 | CN1720033A Water-soluble composition containing coenzyme q10 |
| 01/11/2006 | CN1720032A Method for preventing and/or treating asthma by PBPB |
| 01/11/2006 | CN1720031A Propofol-containing fat emulsions |
| 01/11/2006 | CN1720030A Novel use of lycopene |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1720028A Transdermal analgesic systems with reduced abuse potential |
| 01/11/2006 | CN1720027A Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 01/11/2006 | CN1720026A Sustained release compositions containing alfuzosin |
| 01/11/2006 | CN1720025A Gabapentin tablets and methods for their preparation |
| 01/11/2006 | CN1720020A Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same |
| 01/11/2006 | CN1720019A Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same |
| 01/11/2006 | CN1719984A Sustained improver of muscular fatigue |
| 01/11/2006 | CN1719973A Compositions and methods for cancer diagnosis and therapy |
| 01/11/2006 | CN1718735A Production of polyglutamic acid using na bean bacillus solid fermentation and its product application |
| 01/11/2006 | CN1718590A Poria cocos mycellium glucan sulphate derivative and its preparation method and use |
| 01/11/2006 | CN1718585A Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
| 01/11/2006 | CN1718578A Lerivisiticum extract, its preparation method and medicine containing said extract |
| 01/11/2006 | CN1718577A Medicinal composition containing alkyl acyl ramosqiong and its application |